Sarah Parish

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

Rory Collins, Jane Armitage, Sarah Parish et al. · The Lancet · 2003 · 2.9K citations

Medicine, Cardiology, Pharmacotherapy +13

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight, Peter Sleight, Sarah Parish et al. · PubMed · 1988 · 2.9K citations

Medicine, Cardiology, Internal Medicine +9

ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

Robert T. Collins, R Peto, Marcus Flather et al. · Ghent University Academic Bibliography (Ghent University) · 1995 · 1.1K citations

Medicine, Cardiology, Pharmacology +13

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

Rory Collins, Jane Armitage, Sarah Parish et al. · The Lancet · 2004 · 1.1K citations

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +9